Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis

Identifieur interne : 001444 ( Istex/Corpus ); précédent : 001443; suivant : 001445

Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis

Auteurs : A M Presanis ; R G Pebody ; B J Paterson ; B D M. Tom ; P J Birrell ; A. Charlett ; M. Lipsitch ; D De Angelis

Source :

RBID : ISTEX:E17090920A44354E1A45542EA80F6288D15E1D26

English descriptors

Abstract

Objective To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected. Design A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. Data sources All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza. Main outcome measures Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves. Results In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%). Conclusions This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.

Url:
DOI: 10.1136/bmj.d5408

Links to Exploration step

ISTEX:E17090920A44354E1A45542EA80F6288D15E1D26

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
<author>
<name sortKey="Presanis, A M" sort="Presanis, A M" uniqKey="Presanis A" first="A M" last="Presanis">A M Presanis</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: anne.presanis@mrc-bsu.cam.ac.uk</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pebody, R G" sort="Pebody, R G" uniqKey="Pebody R" first="R G" last="Pebody">R G Pebody</name>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Paterson, B J" sort="Paterson, B J" uniqKey="Paterson B" first="B J" last="Paterson">B J Paterson</name>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tom, B D M" sort="Tom, B D M" uniqKey="Tom B" first="B D M" last="Tom">B D M. Tom</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Birrell, P J" sort="Birrell, P J" uniqKey="Birrell P" first="P J" last="Birrell">P J Birrell</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Charlett, A" sort="Charlett, A" uniqKey="Charlett A" first="A" last="Charlett">A. Charlett</name>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lipsitch, M" sort="Lipsitch, M" uniqKey="Lipsitch M" first="M" last="Lipsitch">M. Lipsitch</name>
<affiliation>
<mods:affiliation>Centre for Communicable Disease Dynamics, Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Angelis, D De" sort="Angelis, D De" uniqKey="Angelis D" first="D De" last="Angelis">D De Angelis</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E17090920A44354E1A45542EA80F6288D15E1D26</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1136/bmj.d5408</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001444</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001444</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
<author>
<name sortKey="Presanis, A M" sort="Presanis, A M" uniqKey="Presanis A" first="A M" last="Presanis">A M Presanis</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: anne.presanis@mrc-bsu.cam.ac.uk</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pebody, R G" sort="Pebody, R G" uniqKey="Pebody R" first="R G" last="Pebody">R G Pebody</name>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Paterson, B J" sort="Paterson, B J" uniqKey="Paterson B" first="B J" last="Paterson">B J Paterson</name>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tom, B D M" sort="Tom, B D M" uniqKey="Tom B" first="B D M" last="Tom">B D M. Tom</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Birrell, P J" sort="Birrell, P J" uniqKey="Birrell P" first="P J" last="Birrell">P J Birrell</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Charlett, A" sort="Charlett, A" uniqKey="Charlett A" first="A" last="Charlett">A. Charlett</name>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lipsitch, M" sort="Lipsitch, M" uniqKey="Lipsitch M" first="M" last="Lipsitch">M. Lipsitch</name>
<affiliation>
<mods:affiliation>Centre for Communicable Disease Dynamics, Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Angelis, D De" sort="Angelis, D De" uniqKey="Angelis D" first="D De" last="Angelis">D De Angelis</name>
<affiliation>
<mods:affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">BMJ</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="ISSN">0959-8138</idno>
<idno type="eISSN">1468-5833</idno>
<imprint>
<publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="2011">2011</date>
<biblScope unit="volume">343</biblScope>
</imprint>
<idno type="ISSN">0959-8138</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0959-8138</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antiviral drugs</term>
<term>Ascertainment</term>
<term>Ascertainment bias</term>
<term>Attack rate</term>
<term>Attack rates</term>
<term>Available information</term>
<term>Bayesian</term>
<term>Bayesian analysis</term>
<term>Bayesian approach</term>
<term>Bayesian evidence synthesis</term>
<term>Behaviour change</term>
<term>Binomial likelihood</term>
<term>Care ratio</term>
<term>Case estimates</term>
<term>Case fatality ratio</term>
<term>Case fatality ratio probability</term>
<term>Case hospitalisation ratio</term>
<term>Case hospitalisation ratios</term>
<term>Case severity ratios</term>
<term>Censoring</term>
<term>Consulting income</term>
<term>Corresponding detection probability</term>
<term>Credible</term>
<term>Credible interval</term>
<term>Credible intervals</term>
<term>Critical revisions</term>
<term>Denominator</term>
<term>Denominator data</term>
<term>Estimation process</term>
<term>Fatality</term>
<term>Febrile illness</term>
<term>First wave</term>
<term>Functional form rationale</term>
<term>Future pandemics</term>
<term>Health protection agency</term>
<term>Health protection agency case estimates</term>
<term>Health protection agency estimates</term>
<term>Health responses</term>
<term>Health service</term>
<term>Healthcare</term>
<term>Hospital admission</term>
<term>Hospitalisation</term>
<term>Hospitalised</term>
<term>Hospitalised cases</term>
<term>Infection</term>
<term>Infection attack rate</term>
<term>Infection attack rates</term>
<term>Infection severity ratios</term>
<term>Infectious diseases</term>
<term>Influenza</term>
<term>Influenza cases</term>
<term>Influenza pandemic</term>
<term>Influenza season</term>
<term>Influenza surveillance systems</term>
<term>Intensive care</term>
<term>Intensive care admission</term>
<term>Intensive care admissions</term>
<term>Mild pandemic</term>
<term>Model assumptions</term>
<term>Model assumptions product</term>
<term>Model development</term>
<term>Model parameters</term>
<term>National institute</term>
<term>National pandemic</term>
<term>Nothing none</term>
<term>Novel pandemic</term>
<term>Older adults</term>
<term>Other studies</term>
<term>Pandemic</term>
<term>Pandemic cases</term>
<term>Pandemic infection</term>
<term>Pandemic influenza</term>
<term>Parametric mixture survival</term>
<term>Population estimates</term>
<term>Population size</term>
<term>Posterior distribution</term>
<term>Posterior summaries</term>
<term>Presanis</term>
<term>Probabilities none</term>
<term>Public health</term>
<term>Public health responses</term>
<term>Real increase</term>
<term>Reprint</term>
<term>Research institute</term>
<term>Research table</term>
<term>Seasonal influenza</term>
<term>Second wave</term>
<term>Sensitivity analyses</term>
<term>Severe events</term>
<term>Severe outcomes</term>
<term>Severity</term>
<term>Severity level</term>
<term>Severity levels</term>
<term>Similar bias</term>
<term>Small sample sizes</term>
<term>Solid lines</term>
<term>Statistical analysis</term>
<term>Subset</term>
<term>Summer wave</term>
<term>Surveillance</term>
<term>Surveillance data</term>
<term>Surveillance system</term>
<term>Surveillance systems</term>
<term>Symptom onset</term>
<term>Symptomatic</term>
<term>Symptomatic attack rates</term>
<term>Symptomatic case fatality ratio</term>
<term>Symptomatic case hospitalisation ratio</term>
<term>Symptomatic case severity</term>
<term>Symptomatic case severity ratios</term>
<term>Symptomatic cases</term>
<term>Symptomatic infection</term>
<term>Symptomatic infections</term>
<term>Test sensitivity</term>
<term>True number</term>
<term>Unbiased</term>
<term>Unbiased information</term>
<term>Year olds</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Objective To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected. Design A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. Data sources All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza. Main outcome measures Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves. Results In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%). Conclusions This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.</div>
</front>
</TEI>
<istex>
<corpusName>bmj</corpusName>
<keywords>
<teeft>
<json:string>hospitalisation</json:string>
<json:string>hospitalised</json:string>
<json:string>pandemic</json:string>
<json:string>pandemic influenza</json:string>
<json:string>model assumptions</json:string>
<json:string>influenza</json:string>
<json:string>infection attack rate</json:string>
<json:string>reprint</json:string>
<json:string>symptomatic cases</json:string>
<json:string>denominator</json:string>
<json:string>intensive care admission</json:string>
<json:string>second wave</json:string>
<json:string>intensive care</json:string>
<json:string>summer wave</json:string>
<json:string>fatality</json:string>
<json:string>bayesian</json:string>
<json:string>severe events</json:string>
<json:string>health protection agency</json:string>
<json:string>symptomatic infections</json:string>
<json:string>case hospitalisation ratio</json:string>
<json:string>ascertainment</json:string>
<json:string>symptomatic case fatality ratio</json:string>
<json:string>presanis</json:string>
<json:string>case fatality ratio</json:string>
<json:string>first wave</json:string>
<json:string>censoring</json:string>
<json:string>intensive care admissions</json:string>
<json:string>health protection agency case estimates</json:string>
<json:string>healthcare</json:string>
<json:string>case estimates</json:string>
<json:string>unbiased</json:string>
<json:string>symptomatic infection</json:string>
<json:string>subset</json:string>
<json:string>severity</json:string>
<json:string>infection</json:string>
<json:string>sensitivity analyses</json:string>
<json:string>surveillance systems</json:string>
<json:string>influenza pandemic</json:string>
<json:string>case severity ratios</json:string>
<json:string>hospitalised cases</json:string>
<json:string>credible intervals</json:string>
<json:string>symptomatic</json:string>
<json:string>severity level</json:string>
<json:string>credible interval</json:string>
<json:string>mild pandemic</json:string>
<json:string>research table</json:string>
<json:string>year olds</json:string>
<json:string>symptomatic case severity ratios</json:string>
<json:string>health protection agency estimates</json:string>
<json:string>infection severity ratios</json:string>
<json:string>severe outcomes</json:string>
<json:string>symptom onset</json:string>
<json:string>parametric mixture survival</json:string>
<json:string>bayesian analysis</json:string>
<json:string>small sample sizes</json:string>
<json:string>infection attack rates</json:string>
<json:string>infectious diseases</json:string>
<json:string>solid lines</json:string>
<json:string>true number</json:string>
<json:string>test sensitivity</json:string>
<json:string>model development</json:string>
<json:string>binomial likelihood</json:string>
<json:string>credible</json:string>
<json:string>febrile illness</json:string>
<json:string>surveillance data</json:string>
<json:string>available information</json:string>
<json:string>national pandemic</json:string>
<json:string>attack rate</json:string>
<json:string>posterior summaries</json:string>
<json:string>estimation process</json:string>
<json:string>surveillance system</json:string>
<json:string>public health responses</json:string>
<json:string>unbiased information</json:string>
<json:string>attack rates</json:string>
<json:string>symptomatic case severity</json:string>
<json:string>severity levels</json:string>
<json:string>influenza season</json:string>
<json:string>bayesian approach</json:string>
<json:string>symptomatic attack rates</json:string>
<json:string>future pandemics</json:string>
<json:string>model parameters</json:string>
<json:string>pandemic infection</json:string>
<json:string>case hospitalisation ratios</json:string>
<json:string>real increase</json:string>
<json:string>corresponding detection probability</json:string>
<json:string>influenza surveillance systems</json:string>
<json:string>research institute</json:string>
<json:string>public health</json:string>
<json:string>bayesian evidence synthesis</json:string>
<json:string>denominator data</json:string>
<json:string>similar bias</json:string>
<json:string>older adults</json:string>
<json:string>behaviour change</json:string>
<json:string>antiviral drugs</json:string>
<json:string>other studies</json:string>
<json:string>health responses</json:string>
<json:string>pandemic cases</json:string>
<json:string>statistical analysis</json:string>
<json:string>critical revisions</json:string>
<json:string>national institute</json:string>
<json:string>consulting income</json:string>
<json:string>novel pandemic</json:string>
<json:string>influenza cases</json:string>
<json:string>seasonal influenza</json:string>
<json:string>population estimates</json:string>
<json:string>case fatality ratio probability</json:string>
<json:string>hospital admission</json:string>
<json:string>health service</json:string>
<json:string>functional form rationale</json:string>
<json:string>symptomatic case hospitalisation ratio</json:string>
<json:string>ascertainment bias</json:string>
<json:string>nothing none</json:string>
<json:string>care ratio</json:string>
<json:string>probabilities none</json:string>
<json:string>model assumptions product</json:string>
<json:string>population size</json:string>
<json:string>posterior distribution</json:string>
<json:string>surveillance</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>A M Presanis</name>
<affiliations>
<json:string>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</json:string>
<json:string>E-mail: anne.presanis@mrc-bsu.cam.ac.uk</json:string>
</affiliations>
</json:item>
<json:item>
<name>R G Pebody</name>
<affiliations>
<json:string>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>B J Paterson</name>
<affiliations>
<json:string>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</json:string>
<json:string>Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</json:string>
</affiliations>
</json:item>
<json:item>
<name>B D M Tom</name>
<affiliations>
<json:string>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>P J Birrell</name>
<affiliations>
<json:string>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>A Charlett</name>
<affiliations>
<json:string>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>M Lipsitch</name>
<affiliations>
<json:string>Centre for Communicable Disease Dynamics, Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>D De Angelis</name>
<affiliations>
<json:string>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</json:string>
<json:string>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>prea843912</json:string>
</articleId>
<arkIstex>ark:/67375/NVC-DM8TBKPH-C</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>research-article</json:string>
</originalGenre>
<abstract>Objective To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected. Design A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. Data sources All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza. Main outcome measures Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves. Results In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%). Conclusions This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.</abstract>
<qualityIndicators>
<score>10</score>
<pdfWordCount>7814</pdfWordCount>
<pdfCharCount>51870</pdfCharCount>
<pdfVersion>1.4</pdfVersion>
<pdfPageCount>14</pdfPageCount>
<pdfPageSize>595.276 x 841.89 pts (A4)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>573</abstractWordCount>
<abstractCharCount>3768</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
<pmid>
<json:string>21903689</json:string>
</pmid>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<title>BMJ</title>
<language>
<json:string>unknown</json:string>
</language>
<issn>
<json:string>0959-8138</json:string>
</issn>
<eissn>
<json:string>1468-5833</json:string>
</eissn>
<publisherId>
<json:string>bmj</json:string>
</publisherId>
<volume>343</volume>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<namedEntities>
<unitex>
<date>
<json:string>2009</json:string>
<json:string>2011</json:string>
<json:string>from 1 June to 31 August</json:string>
<json:string>from June 2009 to February 2010</json:string>
<json:string>3200</json:string>
<json:string>April-July 2009</json:string>
<json:string>2007</json:string>
<json:string>May-June 2009</json:string>
<json:string>2010</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</json:string>
<json:string>RESEARCH Fig</json:string>
<json:string>US and Canada</json:string>
<json:string>Sciences</json:string>
<json:string>National Public Health Service for Wales</json:string>
<json:string>UK Health Protection Agency</json:string>
<json:string>RESEARCH Tables Table</json:string>
<json:string>National Statistics No</json:string>
<json:string>UK Medical Research Council</json:string>
<json:string>RESEARCH Figures Fig</json:string>
<json:string>Health Protection Agency and Department of Health</json:string>
<json:string>RESEARCH Table</json:string>
<json:string>National Institutes of Health</json:string>
<json:string>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB</json:string>
<json:string>National Pandemic Flu Service</json:string>
<json:string>Health Protection Agency</json:string>
<json:string>National Institute of General Medical Sciences</json:string>
<json:string>World Health Organization</json:string>
<json:string>Hunter Medical Research Institute, Australia</json:string>
<json:string>Roche</json:string>
</orgName>
<orgName_funder>
<json:string>Roche</json:string>
</orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>M. Incidence</json:string>
<json:string>Epidemiological</json:string>
<json:string>T. Seroprevalence</json:string>
<json:string>Study</json:string>
<json:string>The</json:string>
<json:string>M. Concurrent</json:string>
<json:string>August September</json:string>
<json:string>Miller</json:string>
<json:string>License</json:string>
</persName>
<placeName>
<json:string>Stanford</json:string>
<json:string>United States</json:string>
<json:string>UK</json:string>
<json:string>Milwaukee</json:string>
<json:string>Hong Kong</json:string>
<json:string>London</json:string>
<json:string>New York City</json:string>
<json:string>Boston</json:string>
<json:string>Atlanta</json:string>
<json:string>New Zealand</json:string>
<json:string>United Kingdom</json:string>
<json:string>York</json:string>
<json:string>MA</json:string>
<json:string>Cambridge</json:string>
<json:string>England</json:string>
</placeName>
<ref_url>
<json:string>http://www.bmj.com/subscribe</json:string>
<json:string>http://creativecommons.org/licenses/bync/</json:string>
<json:string>http://creativecommons.org/licenses/by-nc/</json:string>
<json:string>http://www.bmj.com/permissions</json:string>
</ref_url>
<ref_bibl>
<json:string>August-September 2009</json:string>
<json:string>Presanis et al</json:string>
<json:string>Miller et al.</json:string>
<json:string>England, 2009</json:string>
<json:string>April 2009</json:string>
<json:string>Pebody et al</json:string>
<json:string>August 200922</json:string>
<json:string>Hardelid et al</json:string>
<json:string>Hadler et al</json:string>
<json:string>Baker et al</json:string>
<json:string>Donaldson et al</json:string>
<json:string>Garske et al</json:string>
<json:string>Nishiura et al</json:string>
<json:string>Wu et al</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/NVC-DM8TBKPH-C</json:string>
</ark>
<categories>
<wos></wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - general & internal medicine</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - General Medicine</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<doi>
<json:string>10.1136/bmj.d5408</json:string>
</doi>
<id>E17090920A44354E1A45542EA80F6288D15E1D26</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher scheme="https://publisher-list.data.istex.fr">British Medical Journal Publishing Group</publisher>
<availability status="free">
<p>Open Access</p>
</availability>
<date>2011</date>
</publicationStmt>
<notesStmt>
<note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
<author xml:id="author-0000" corresp="yes">
<persName>
<forename type="first">A M</forename>
<surname>Presanis</surname>
</persName>
<email>anne.presanis@mrc-bsu.cam.ac.uk</email>
<note type="biography">investigator statistician</note>
<affiliation>investigator statistician</affiliation>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">R G</forename>
<surname>Pebody</surname>
</persName>
<note type="biography">consultant epidemiologist</note>
<affiliation>consultant epidemiologist</affiliation>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">B J</forename>
<surname>Paterson</surname>
</persName>
<note type="biography">research fellow in epidemiology</note>
<affiliation>research fellow in epidemiology</affiliation>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
<affiliation>Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">B D M</forename>
<surname>Tom</surname>
</persName>
<note type="biography">investigator scientist</note>
<affiliation>investigator scientist</affiliation>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">P J</forename>
<surname>Birrell</surname>
</persName>
<note type="biography">career development fellow in biostatistics</note>
<affiliation>career development fellow in biostatistics</affiliation>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
</author>
<author xml:id="author-0005">
<persName>
<forename type="first">A</forename>
<surname>Charlett</surname>
</persName>
<note type="biography">Head of statistics, modelling and economics department</note>
<affiliation>Head of statistics, modelling and economics department</affiliation>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
</author>
<author xml:id="author-0006">
<persName>
<forename type="first">M</forename>
<surname>Lipsitch</surname>
</persName>
<note type="biography">professor of epidemiology</note>
<affiliation>professor of epidemiology</affiliation>
<affiliation>Centre for Communicable Disease Dynamics, Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA</affiliation>
</author>
<author xml:id="author-0007">
<persName>
<forename type="first">D De</forename>
<surname>Angelis</surname>
</persName>
<note type="biography">senior statistician</note>
<affiliation>senior statistician</affiliation>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
</author>
<idno type="istex">E17090920A44354E1A45542EA80F6288D15E1D26</idno>
<idno type="ark">ark:/67375/NVC-DM8TBKPH-C</idno>
<idno type="DOI">10.1136/bmj.d5408</idno>
<idno type="href">bmj-343-bmj-d5408.pdf</idno>
<idno type="article-id">prea843912</idno>
<idno type="local">bmj;343/sep08_1/d5408</idno>
</analytic>
<monogr>
<title level="j">BMJ</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="pISSN">0959-8138</idno>
<idno type="eISSN">1468-5833</idno>
<idno type="publisher-id">bmj</idno>
<idno type="PublisherID-hwp">bmj</idno>
<idno type="PublisherID-nlm-ta">BMJ</idno>
<imprint>
<publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="2011"></date>
<biblScope unit="volume">343</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2011</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract>
<p>Objective To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected. Design A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. Data sources All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza. Main outcome measures Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves. Results In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%). Conclusions This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.</p>
</abstract>
</profileDesc>
<revisionDesc>
<change when="2011">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType>
<istex:document>
<article article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">bmj</journal-id>
<journal-id journal-id-type="nlm-ta">BMJ</journal-id>
<journal-id journal-id-type="publisher-id">bmj</journal-id>
<journal-title>BMJ</journal-title>
<abbrev-journal-title abbrev-type="publisher">BMJ</abbrev-journal-title>
<issn pub-type="ppub">0959-8138</issn>
<issn pub-type="epub">1468-5833</issn>
<publisher>
<publisher-name>British Medical Journal Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">prea843912</article-id>
<article-id pub-id-type="doi">10.1136/bmj.d5408</article-id>
<article-id pub-id-type="other">bmj;343/sep08_1/d5408</article-id>
<article-id pub-id-type="other">bmj;bmj.d5408</article-id>
<article-id pub-id-type="other">sep08_1</article-id>
<article-id pub-id-type="other">bmj.d5408</article-id>
<article-id pub-id-type="other">bmj.d5408</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Presanis</surname>
<given-names>A M</given-names>
</name>
<role>investigator statistician</role>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Pebody</surname>
<given-names>R G</given-names>
</name>
<role>consultant epidemiologist</role>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Paterson</surname>
<given-names>B J</given-names>
</name>
<role>research fellow in epidemiology</role>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Tom</surname>
<given-names>B D M</given-names>
</name>
<role>investigator scientist</role>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Birrell</surname>
<given-names>P J</given-names>
</name>
<role>career development fellow in biostatistics</role>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Charlett</surname>
<given-names>A</given-names>
</name>
<role>Head of statistics, modelling and economics department</role>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Lipsitch</surname>
<given-names>M</given-names>
</name>
<role>professor of epidemiology</role>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="no">
<name>
<surname>Angelis</surname>
<given-names>D De</given-names>
</name>
<role>senior statistician</role>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<aff id="aff1">
<label>1</label>
Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</aff>
<aff id="aff2">
<label>2</label>
Health Protection Agency Health Protection Services, London NW9 5EQ, UK</aff>
<aff id="aff3">
<label>3</label>
Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</aff>
<aff id="aff4">
<label>4</label>
Centre for Communicable Disease Dynamics, Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence to: A M Presanis
<email>anne.presanis@mrc-bsu.cam.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2011</year>
</pub-date>
<pub-date pub-type="epub-original">
<year>2011</year>
</pub-date>
<volume>343</volume>
<volume-id pub-id-type="other">343</volume-id>
<volume-id pub-id-type="other">343</volume-id>
<elocation-id>d5408</elocation-id>
<history>
<date date-type="accepted">
<day>27</day>
<month>June</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© Presanis et al 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder>Presanis et al</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See:
<ext-link xlink:href="http://creativecommons.org/licenses/by-nc/2.0/" ext-link-type="uri">http://creativecommons.org/licenses/by-nc/2.0/</ext-link>
and
<ext-link xlink:href="http://creativecommons.org/licenses/by-nc/2.0/legalcode" ext-link-type="uri">http://creativecommons.org/licenses/by-nc/2.0/legalcode</ext-link>
.</p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:role="full-text" xlink:href="bmj-343-bmj-d5408.pdf"></self-uri>
<abstract>
<p>
<bold>Objective</bold>
To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected.</p>
<p>
<bold>Design</bold>
A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. </p>
<p>
<bold>Data sources</bold>
All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza.</p>
<p>
<bold>Main outcome measures </bold>
Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves.</p>
<p>
<bold>Results</bold>
In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%).</p>
<p>
<bold>Conclusions</bold>
This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.</p>
</abstract>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis</title>
</titleInfo>
<name type="personal" displayLabel="corresp">
<namePart type="given">A M</namePart>
<namePart type="family">Presanis</namePart>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
<affiliation>E-mail: anne.presanis@mrc-bsu.cam.ac.uk</affiliation>
<description>investigator statistician</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R G</namePart>
<namePart type="family">Pebody</namePart>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
<description>consultant epidemiologist</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B J</namePart>
<namePart type="family">Paterson</namePart>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
<affiliation>Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia</affiliation>
<description>research fellow in epidemiology</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B D M</namePart>
<namePart type="family">Tom</namePart>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
<description>investigator scientist</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P J</namePart>
<namePart type="family">Birrell</namePart>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
<description>career development fellow in biostatistics</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="family">Charlett</namePart>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
<description>Head of statistics, modelling and economics department</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Lipsitch</namePart>
<affiliation>Centre for Communicable Disease Dynamics, Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA</affiliation>
<description>professor of epidemiology</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D De</namePart>
<namePart type="family">Angelis</namePart>
<affiliation>Medical Research Council Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge CB2 0SR, UK</affiliation>
<affiliation>Health Protection Agency Health Protection Services, London NW9 5EQ, UK</affiliation>
<description>senior statistician</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>British Medical Journal Publishing Group</publisher>
<dateIssued encoding="w3cdtf">2011</dateIssued>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract>Objective To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected. Design A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. Data sources All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza. Main outcome measures Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves. Results In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%). Conclusions This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.</abstract>
<relatedItem type="host">
<titleInfo>
<title>BMJ</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>BMJ</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">0959-8138</identifier>
<identifier type="eISSN">1468-5833</identifier>
<identifier type="PublisherID">bmj</identifier>
<identifier type="PublisherID-hwp">bmj</identifier>
<identifier type="PublisherID-nlm-ta">BMJ</identifier>
<part>
<date>2011</date>
<detail type="volume">
<caption>vol.</caption>
<number>343</number>
</detail>
</part>
</relatedItem>
<identifier type="istex">E17090920A44354E1A45542EA80F6288D15E1D26</identifier>
<identifier type="ark">ark:/67375/NVC-DM8TBKPH-C</identifier>
<identifier type="DOI">10.1136/bmj.d5408</identifier>
<identifier type="href">bmj-343-bmj-d5408.pdf</identifier>
<identifier type="ArticleID">prea843912</identifier>
<identifier type="local">bmj;343/sep08_1/d5408</identifier>
<accessCondition type="use and reproduction" contentType="open-access">This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</recordContentSource>
<recordOrigin>© Presanis et al 2011</recordOrigin>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/record.json</uri>
</json:item>
</metadata>
<annexes>
<json:item>
<extension>jpeg</extension>
<original>true</original>
<mimetype>image/jpeg</mimetype>
<uri>https://api.istex.fr/ark:/67375/NVC-DM8TBKPH-C/annexes.jpeg</uri>
</json:item>
</annexes>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001444 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001444 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:E17090920A44354E1A45542EA80F6288D15E1D26
   |texte=   Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021